한약재의 Cytochrome P450 결합관련 안전성에 관한 연구
A Study on the Affinity of Some Medicinal Herbs to Two Cytochrome P450 Subfamilies, CYP3A4 and CYP2D6
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives : This study was performed to investigate the metabolic site of some medicinal herbs in the liver associated with CYP (Cytochrome P450). Methods : Cytochrome P450 is the major enzymes involved in drug metabolism and bioactivation. CYP3A4 and CYP2D6, the major CYP isoforms in humans, catalyse the major proportion of drugs available on the market. Scintillation proximity assay (SPA) is often used in studies to identify compounds that inhibit CYP3A4 and CYP2D6. 28 herbal extracts and radioisotopes were attached competitively to SPA beads, and followed by measuring the remaining radioisotopes in the medium. Erythromycin and dexamethasone, inhibitors of CYP3A4 and CYP2D6, were used as controls respectively. Results : Most of the 28 herbal extracts showed dose-dependent affinity to the CYP3A4 while some of the herbs showed affinity to the CYP2D6. Conclusions : These results suggest that most of the 28 herbal extracts are metabolized safely in the liver, combined with CYP3A4 and CYP2D6.
Abstract
Objectives : This study was performed to investigate the metabolic site of some medicinal herbs in the liver associated with CYP (Cytochrome P450). Methods : Cytochrome P450 is the major enzymes involved in drug metabolism and bioactivation. CYP3A4 and CYP2D6, the major CYP isoforms in humans, catalyse the major proportion of drugs available on the market. Scintillation proximity assay (SPA) is often used in studies to identify compounds that inhibit CYP3A4 and CYP2D6. 28 herbal extracts and radioisotopes were attached competitively to SPA beads, and followed by measuring the remaining radioisotopes in the medium. Erythromycin and dexamethasone, inhibitors of CYP3A4 and CYP2D6, were used as controls respectively. Results : Most of the 28 herbal extracts showed dose-dependent affinity to the CYP3A4 while some of the herbs showed affinity to the CYP2D6. Conclusions : These results suggest that most of the 28 herbal extracts are metabolized safely in the liver, combined with CYP3A4 and CYP2D6.
참고문헌 (30)
- 윤영주, "한약 복용이 간기능에 미치는 영향: 국내 문헌에 대한 체계적 고찰", 대한한방내과학회지, 30(1), pp.153~172 (2009), 대한한방내과학회
- Schiano TD, "Hepatotoxicity and complementary and alternative medicines", Clin Liver Dis, 7(2), pp.453~473 (2003)
- 조재철, "한약 하수오(Ho-Shou-Wu) 복용 후 발생한 급성 간염 1예", 대한내과학회지, 56(6), pp.753~756 (1999)
- 서재석, "느릅나무 달인 물 복용후 발생한 급성 간염과 급성신부전 1예", 전북의대논문집, 24(2), pp.197~201 (2000)
- 강선형, "급성 독성간염 159예의 임상적 고찰", Clinical and Molecular Hepatology, 14(4), pp.483~492 (2008), 대한간학회
- 이승환, "최근 10년간 광주 전남지역에서 발생한 약인성 간손상의 임상적 고찰", 대한간학회지, 13(3s), pp.s109~ (2007)
- 서영호, "한약 및 건강식품에 의한 간손상 환자의 임상적 분석", 대한간학회지, 7(2s), pp.s95~ (2001)
- 윤영주, "약인성 간손상의 원인물질에 관한 국내연구의 체계적 고찰", 대한한의학회지, 30(2), pp.30~45 (2009), 대한한의학회
- Pittler MH, "Systematic Review : hepatotoxic events associaed with herbal medicinal products", Aliment Pharmacol Ther, 18, pp.451~471 (2003)
- MacPherson H, "The safety of Chinese herbal medicine : A pilot Study for a national survey", J Altern Complement Med, 11(4), pp.617~626 (2005)
- 정한수, "증례를 통해 본 한약투여가 간질환 환자의 간손상에 미치는 영향", 대한한방내과학회지, 21(2), pp.349~354 (2000)
- 윤여광, "장기간의 한약 투여가 간기능에 미치는 영향에 대한 임상적 고찰", 대한한방성인병학회지, 8(1), pp.30~34 (2002)
- 김병운, "만성간염 3,136례에 대한 임상분석과 생간건비탕의 치료효과", 대한한의학회지, 14(1), pp.216~223 (1993)
- 이용연, "가미청간산을 투여한 알콜성 간질환 환자 25례에 대한 임상보고", 대한한방내과학회지, 22(4), pp.613~619 (2001)
- 이은형, "한약과 양약의 병용 치료를 통한 약인성 간손상 치험례 1례", 동의생리병리학회지, 21(1), pp.285~290 (2007), 대한동의병리학회
- 천진홍, "한약인성 간손상의 원인산정법으로 도입된 진단 척도(Modified RUCAM scale)에 대한 임상적 고찰", 대한한방소아과학회지, 22(3), pp.83~94 (2008), 대한한방소아과학회
- 김경아, "인체 간 Microsome에서의 우슬 추출물의 Cytochrome P450약물 대사효소에 대한 억제작용", 대한한의학회지, 24(2), pp.40~46 (2003), 대한한의학회
- Hiroshi I, "Inhibition of human liver microsomal CYP3A4 and CYP2D6 by extracts from 78 herbal medicines", J Trad Med, 21, pp.42~50 (2004)
- 지형준, "대한약전 및 대한약전외 한약규격주해", pp.61~62 (1998), 한국메디칼인덱스사
- 신성재, "한국인에서 전격성 간부전의 임상적 특징 및 예후 인자", Clinical and Molecular Hepatology, 10(4), pp.298~307 (2004), 대한간학회
- Jeong TY, "A prospective study on the safety of herbal medicines, used alone or with conventional medicines", J Ethnopharmacol, 143(3), pp.884~888 (2012)
- Kim NH, "Liver enzyme abnormalities during concurrent use of herbal and conventional medicines in Korea: A retrospective study", Phytomedicine, 18, pp.1208~1213 (2011)
- Guengerich FP, "Cytochromes P450, drugs, and diseases", Mol Interv, 3(4), pp.194~204 (2003)
- 오정미, "약물대사효소의 유전적 다형성 및 임상적 응용", 한국임상약학회지, 16(2), pp.155~164 (2006), 한국임상약학회
- 임동석, "약물 상호작용의 이해", 대한의사협회지, 49(1), pp.78~85 (2006)
- Gonzalez FJ, "The molecular biology of cytochrome P450s", Pharmacol Rev, 40, pp.243~288 (1988)
- Guengerich FP, "Analysis and characterization of enezymes, In Principles and Methods of Toxicology", pp.1259~1313 (1984), Raven Press
- Brattin WJ, "Pathological mechanisms in carbon tetrachloride hepatotoxicity", J Free Radic Biol Med, 1(1), pp.27~38 (1985)
- Recknagel RO, "Mechanisms of carbon tetrachloride toxicity", Pharmacol Ther, 43(1), pp.139~154 (1989)
- Williams AT, "Carbon tetrachloride hepatotoxicity: an example of free radical- mediated injury", Semin Liver Dis, 10(4), pp.279~284 (1990)